含有环极的药物输送系统及其在神经退行性疾病中的应用
Yuan Xing1, Bohan Meng1, Qi Chen1,2
1MOE Key Laboratory for Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou 350108, China.
International journal of molecular sciences
|October 16, 2024
概括
环极素 (循环葡萄糖单位) 增强药物溶解性和药物输送. 修改后的环极素通过与生物屏障相互作用,显示出治疗神经退行性疾病的潜力.
科学领域:
- 制药科学 制药科学
- 药物运输 药物运输 药物运输
- 药用化学 医学化学
背景情况:
- 环极素 (CDs) 是具有疏水内和疏水外的循环葡萄糖单位.
- 这种两味性质有利于与脂质亲和性和水友性化合物的相互作用.
- 磁盘被广泛用作药物辅助剂,以提高药物的溶解性,并制定先进的药物输送系统.
研究的目的:
- 审查循环德克斯特林及其衍生物的基本特性.
- 总结了循环德克斯在神经退行性疾病的药物输送系统中的应用.
- 突显环氧在克服血脑屏障等生物障碍方面的潜力.
主要方法:
- 文献综述巩固了环极素及其衍生物的关键特征.
- 关于在神经退行性疾病治疗中使用环氧德克斯的现有研究的总结.
- 对环极素与细胞组件和物理障碍物的相互作用进行分析.
主要成果:
- 环极素有效地提高了难以溶解的药物的溶解性.
- 修改后的循环德克斯特林在跨越血脑屏障的向药物输送方面表现出潜力.
- 它们与生物系统的相互作用提供了各种治疗效果.
结论:
- 环极素是多功能药品辅助剂,在药物输送方面具有显著的潜力.
- 修改后的环极素为治疗神经退行性疾病提供了有希望的策略.
- 进一步研究基于循环德克斯的系统对于先进的治疗应用是有必要的.
相关概念视频
Drug Delivery: Miscellaneous Routes
329
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
329
Drug Delivery: Parenteral Route
438
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
438
Alzheimer's Disease: Treatment
166
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
166
Parkinson's Disease: Overview
487
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
487
Parkinson's Disease: Treatment
231
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
231
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
106
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
106


